Loading...
The influence of subclonal resistance mutations on targeted cancer therapy
Clinical oncology is being revolutionized by the increasing use of molecularly targeted therapies. This paradigm holds great promise for improving cancer treatment; however, allocating specific therapies to the patients who are most likely to derive a durable benefit continues to represent a conside...
Na minha lista:
| Udgivet i: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838548/ https://ncbi.nlm.nih.gov/pubmed/26483300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.175 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|